Minimal residual disease interpreter for flow- or NGS-based MRD percentage values.
Waiting For Required Inputs
Complete the required fields to generate the oncology interpretation.
Guidelines & Evidence
Clinical Details
Section 1
When to Use
Primary Use
Minimal residual disease interpreter for flow- or NGS-based MRD percentage values.
Section 2
Formula & Logic
Clinical Inputs
MRD burden
%
Interpretive Logic
Interpret assay burden in the context of the platform used.
Trend MRD using the same assay whenever possible.
Section 3
Pearls/Pitfalls
Result Bands
<0.01%
Below common lower flow thresholds / MRD-negative framework
0.01-0.09%
Low-level positivity
0.1-0.99%
Quantifiable positivity
>=1%
High-level residual disease
Section 4
Next Steps
Suggested Next Steps
01
Interpret the result in the full disease-specific clinical context.
02
Correlate with pathology, imaging, performance status, and multidisciplinary guidance.
Section 5
Evidence Appraisal
Evidence Base
Minimal residual disease interpreter for flow- or NGS-based MRD percentage values.
OpiCalc Medical Oncology Module • Haematological Malignancies. 2026;Logic implemented from widely used contemporary oncology classification, prognostic, and response-assessment frameworks.
Section 6
Literature
Context
MRD Assessment Framework is included in the oncology module as a structured decision-support tool for haematological malignancies workflows.
